Literature DB >> 33221372

The biology of Acanthamoeba keratitis.

Jerry Y Niederkorn1.   

Abstract

Acanthamoeba keratitis (AK) is a rare protozoal infection of the cornea. At least eight species of Acanthamoeba are known to cause this sight-threatening disease of the ocular surface. Acanthamoeba spp. exist in a wide array of niches ranging from thermal springs to under ice and every conceivable habitat in between. Contact lens wear is the leading risk factor for AK and is practiced by over 30 million individuals in the United States, yet the incidence of AK is less than 33 cases per one million contact lens wearers. Serological studies have reported that 90%-100% of individuals with no history of AK possess antibodies specific for Acanthamoeba antigens indicating that exposure to this organism is commonplace, yet disease is remarkably rare. Animal studies have shed light on the pathobiology and immunobiology of AK and indicate that a constellation of factors including the ocular surface microbiome and the microbiome of Acanthamoeba itself contribute to the pathogenesis of AK. Interesting, secretory antibodies produced by the adaptive immune response can prevent the initiation of corneal infection, but once Acanthamoeba trophozoites breach the corneal epithelium the adaptive immune system is helpless in altering the course of AK. It has been almost 50 years since AK was first described, yet many questions remain unanswered about this curious and enigmatic disease of the ocular surface.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acanthamoeba; Contact lens; Cornea; Immunology; Keratitis; Microbiome; Pathology

Mesh:

Substances:

Year:  2020        PMID: 33221372      PMCID: PMC7856181          DOI: 10.1016/j.exer.2020.108365

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  74 in total

Review 1.  The pathophysiology of Acanthamoeba keratitis.

Authors:  Daniel W Clarke; Jerry Y Niederkorn
Journal:  Trends Parasitol       Date:  2006-02-24

2.  Enhancement of in vitro cytopathogenicity by Acanthamoeba spp. following acquisition of bacterial endosymbionts.

Authors:  T R Fritsche; D Sobek; R K Gautom
Journal:  FEMS Microbiol Lett       Date:  1998-09-15       Impact factor: 2.742

Review 3.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

4.  The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.

Authors:  Dana Robaei; Nicole Carnt; Darwin C Minassian; John K G Dart
Journal:  Ophthalmology       Date:  2014-03-14       Impact factor: 12.079

5.  Adaptive immune responses to Acanthamoeba cysts.

Authors:  Kathy McClellan; Kevin Howard; Elizabeth Mayhew; Jerry Niederkorn; Hassan Alizadeh
Journal:  Exp Eye Res       Date:  2002-09       Impact factor: 3.467

6.  A Rabbit Model of Acanthamoeba Keratitis That Better Reflects the Natural Human Infection.

Authors:  Xianmin Feng; Wenyu Zheng; Yuehua Wang; Donghai Zhao; Xiaoming Jiang; Shijie Lv
Journal:  Anat Rec (Hoboken)       Date:  2015-04-17       Impact factor: 2.064

7.  Immunopathology and electron microscopy of Acanthamoeba keratitis.

Authors:  W Mathers; G Stevens; M Rodrigues; C C Chan; J Gold; G S Visvesvara; M A Lemp; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1987-05-15       Impact factor: 5.258

8.  Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis.

Authors:  I Kremer; E J Cohen; R C Eagle; I Udell; P R Laibson
Journal:  CLAO J       Date:  1994-01

9.  The rising tide of Acanthamoeba keratitis in Auckland, New Zealand: a 7-year review of presentation, diagnosis and outcomes (2009-2016).

Authors:  James McKelvie; Moaz Alshiakhi; Mohammed Ziaei; Dipika V Patel; Charles Nj McGhee
Journal:  Clin Exp Ophthalmol       Date:  2018-03-05       Impact factor: 4.207

Review 10.  Pathobiology and Immunobiology of Acanthamoeba Keratitis: Insights from Animal Models
.

Authors:  Sudha Neelam; Jerry Y Niederkorn
Journal:  Yale J Biol Med       Date:  2017-06-23
View more
  4 in total

1.  Tannic Acid-Modified Silver Nanoparticles in Conjunction with Contact Lens Solutions Are Useful for Progress against the Adhesion of Acanthamoeba spp. to Contact Lenses.

Authors:  Marcin Padzik; Lidia Chomicz; Julita Bluszcz; Karolina Maleszewska; Jaroslaw Grobelny; David Bruce Conn; Edyta B Hendiger
Journal:  Microorganisms       Date:  2022-05-24

Review 2.  Resident Innate Immune Cells in the Cornea.

Authors:  Jun Liu; Zhijie Li
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

3.  Amoebicidal activity of cationic carbosilane dendrons derived with 4-phenylbutyric acid against Acanthamoeba griffini and Acanthamoeba polyphaga trophozoites and cysts.

Authors:  P López-Barona; C Verdú-Expósito; T Martín-Pérez; N Gómez-Casanova; T Lozano-Cruz; P Ortega; R Gómez; J Pérez-Serrano; I Heredero-Bermejo
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

4.  Silver Nanoparticles Conjugated with Contact Lens Solutions May Reduce the Risk of Acanthamoeba Keratitis.

Authors:  Edyta B Hendiger; Marcin Padzik; Inés Sifaoui; María Reyes-Batlle; Atteneri López-Arencibia; Diana Zyskowska; Marta Grodzik; Anna Pietruczuk-Padzik; Jacek Hendiger; Gabriela Olędzka; Lidia Chomicz; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.